Skip to main content
. 2022 Jun 22;12:10601. doi: 10.1038/s41598-022-14790-x

Table 3.

Effect of the compound on the viability of BHK-21 cells (CC50) and the viral replication of CHIKV (EC50) in 16 h treatment.

Compound Type of the Assay CC50 EC50 Selectivity index (SI)
LabMol-309 CHIKV-nanoluc and BHK-21 cells 52 5.2 10
BHK-CHIKV replicon 17.1 10.0 1.7